Suthipong Chujan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suthipong Chujan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Jutamaad Satayavivad
Environmental Toxicology Program, Chulabhorn Graduate Institute, Bangkok 10210, Thailand
5 shared publications - Nutsira Vajeethaveesin
Environmental Toxicology Program, Chulabhorn Graduate Institute, Bangkok 10210, Thailand
3 shared publications - Jantamas Kanitwithayanun
Environmental Toxicology Program, Chulabhorn Graduate Institute, Bangkok, Thailand
1 shared publication Jutamaad Satayavivad
Laboratory of Pharmacology, Chulabhorn Research Institute, Bangkok, 10210, Thailand
1 shared publicationNanthanit Pholphana
Laboratory of Pharmacology, Chulabhorn Research Institute, Bangkok, 10210, Thailand
1 shared publicationNoppawan Rittapai
Laboratory of Pharmacology, Chulabhorn Research Institute, Bangkok, 10210, Thailand
1 shared publication
Latest Publications
- Open Access
- 18 November 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (7) , 797
Quercetin Alleviates PFOS-Induced Inflammatory Responses in Human Microvascular Endothelial Cells
Background: Perfluorooctane sulfonic acid (PFOS) is a ubiquitous industrial chemical linked to cardiovascular toxicity. Quercetin, a plant-derived flavonoid, exhibits known anti-inflammatory properties. While PFOS induces endothelial dysfunctions, the molecular mechanisms underlying quercetin’s protective effects remain unclear. Methods: We integrated transcriptomic analysis and in vitro experiments to investigate these mechanisms in human microvascular endothelial cells (HMEC-1). Results: Five overlapping hub genes between PFOS and quercetin targets (IL6, RELA, VEGFA, CXCL8 and PIM1) were identified. Enrichment and protein–protein interaction network analyses showed the AGE–RAGE signaling pathway and cytokine activity as primary mediators. Furthermore, these five hub genes were significantly up-regulated in human atheromatous plaque tissues (GSE43292). Crucially, an independent external validation using a Logistic Regression machine learning model on an external dataset (GSE100927) demonstrated the strong predictive power of these five overlapping hub genes (AUC = 0.82) in classifying atherosclerotic lesions, effectively mitigating internal validation bias and strongly supporting their clinical diagnostic relevance. To verify these findings, we demonstrated that PFOS exposure induced p65 phosphorylation, up-regulated VEGFA and ICAM1, and down-regulated SIRT1 and SOCS3 expression in HMEC-1 cells. Quercetin co-treatment effectively reversed these molecular alterations, suppressing p65 phosphorylation and VEGFA/ICAM1 expression, while restoring SIRT1 and SOCS3 levels. Conclusions: These findings provide novel insights into how quercetin alleviates PFOS-induced inflammatory responses associated with endothelial activation.
- 18 November 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (7) , 797
Open AccessQuercetin Alleviates PFOS-Induced Inflammatory Responses in Human Microvascular Endothelial Cells
Background: Perfluorooctane sulfonic acid (PFOS) is a ubiquitous industrial chemical linked to cardiovascular toxicity. Quercetin, a plant-derived flavonoid, exhibits known anti-inflammatory properties. While PFOS induces endothelial dysfunctions, the molecular mechanisms underlying quercetin’s protective effects remain unclear. Methods: We integrated transcriptomic analysis and in vitro experiments to investigate these mechanisms in human microvascular endothelial cells (HMEC-1). Results: Five overlapping hub genes between PFOS and quercetin targets (IL6, RELA, VEGFA, CXCL8 and PIM1) were identified. Enrichment and protein–protein interaction network analyses showed the AGE–RAGE signaling pathway and cytokine activity as primary mediators. Furthermore, these five hub genes were significantly up-regulated in human atheromatous plaque tissues (GSE43292). Crucially, an independent external validation using a Logistic Regression machine learning model on an external dataset (GSE100927) demonstrated the strong predictive power of these five overlapping hub genes (AUC = 0.82) in classifying atherosclerotic lesions, effectively mitigating internal validation bias and strongly supporting their clinical diagnostic relevance. To verify these findings, we demonstrated that PFOS exposure induced p65 phosphorylation, up-regulated VEGFA and ICAM1, and down-regulated SIRT1 and SOCS3 expression in HMEC-1 cells. Quercetin co-treatment effectively reversed these molecular alterations, suppressing p65 phosphorylation and VEGFA/ICAM1 expression, while restoring SIRT1 and SOCS3 levels. Conclusions: These findings provide novel insights into how quercetin alleviates PFOS-induced inflammatory responses associated with endothelial activation.
- 23 June 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Effects of 7-hydroxymitragynine on serotonin, amino acid profiles, and ion homeostasis in SH-SY5Y cells
7-Hydroxymitragynine (7-HMG), an indole-based alkaloid obtained from Mitragyna speciosa Korth, is also formed through hepatic cytochrome P450 (CYP450)-mediated metabolism of mitragynine in humans and exhibits strong neuromodulatory activity, but its cellular biological effects on neuronal systems remain insufficiently defined. In this study, we investigated the biochemical and ion-omic responses of SH-SY5Y neuroblastoma cells following 7-HMG exposure. Metabolite profiling revealed significant elevations in multiple intracellular amino acids, including Asp, Gly, Gln, Ser, Met, Leu, Lys, Thr, Val, and Tyr, suggesting alterations in amino acid metabolism associated with cellular stress responses. Notably, intracellular serotonin (5-HT) levels decreased while extracellular 5-HT concentrations increased, suggesting dysregulation of serotonin storage and release mechanisms. ICP-MS analysis demonstrated substantial alterations in Ca²⁺ and Mg²⁺ homeostasis, with increases in intracellular Ca²⁺ and Mg²⁺, along with elevated extracellular Mg²⁺. These changes indicate perturbation of ion-transport systems and intracellular signaling processes relevant to neuronal function. Together, these findings show that 7-HMG induced significant metabolic and ionic disturbances in neuronal cells, providing new mechanistic insight into its neurobiological activity and potential neurotoxicity.
- 23 June 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Effects of 7-hydroxymitragynine on serotonin, amino acid profiles, and ion homeostasis in SH-SY5Y cells
7-Hydroxymitragynine (7-HMG), an indole-based alkaloid obtained from Mitragyna speciosa Korth, is also formed through hepatic cytochrome P450 (CYP450)-mediated metabolism of mitragynine in humans and exhibits strong neuromodulatory activity, but its cellular biological effects on neuronal systems remain insufficiently defined. In this study, we investigated the biochemical and ion-omic responses of SH-SY5Y neuroblastoma cells following 7-HMG exposure. Metabolite profiling revealed significant elevations in multiple intracellular amino acids, including Asp, Gly, Gln, Ser, Met, Leu, Lys, Thr, Val, and Tyr, suggesting alterations in amino acid metabolism associated with cellular stress responses. Notably, intracellular serotonin (5-HT) levels decreased while extracellular 5-HT concentrations increased, suggesting dysregulation of serotonin storage and release mechanisms. ICP-MS analysis demonstrated substantial alterations in Ca²⁺ and Mg²⁺ homeostasis, with increases in intracellular Ca²⁺ and Mg²⁺, along with elevated extracellular Mg²⁺. These changes indicate perturbation of ion-transport systems and intracellular signaling processes relevant to neuronal function. Together, these findings show that 7-HMG induced significant metabolic and ionic disturbances in neuronal cells, providing new mechanistic insight into its neurobiological activity and potential neurotoxicity.
- Open Access
- 24 October 2025
- Published by MDPI AG in Informatics
- Vol. 12 (4) , 116
Computational Analysis of Zingiber officinale Identifies GABAergic Signaling as a Potential Therapeutic Mechanism in Colorectal Cancer
Colorectal cancer cases are on the rise and have become a leading cause of cancer-related deaths. Ginger (Zingiber officinale) is widely used in traditional herbal medicine and has been proposed as a potential treatment for colorectal cancer. This study aimed to explore the network pharmacology and pharmacodynamics of ginger in colorectal cancer treatment. Colorectal cancer patient data from the GEO dataset were analyzed to identify differentially expressed genes (DEGs). Six key components of ginger were selected based on specific criteria, and their target proteins were predicted using the TCMSP database. By overlapping DEGs with predicted targets, 36 candidate drug targets were identified. These targets were analyzed for biological alterations, pathway enrichment, protein–protein interactions, and hub-gene selection, integrating network pharmacology. Molecular docking simulations were conducted to confirm the binding interactions between ginger components and target proteins. The findings showed that GABAergic signaling and apoptosis were the most enriched pathways, suggesting their potential role in colorectal cancer treatment. Docking simulations further revealed that ginger’s active compounds bind to COX2 and ESR1, indicating anti-inflammatory effects and modulation of estrogenic activity. This study provides insight into the systemic mechanisms of ginger in colorectal cancer treatment through an integrated “drug–gene–pathway–disease” network approach.
- 24 October 2025
- Published by MDPI AG in Informatics
- Vol. 12 (4) , 116
Open AccessComputational Analysis of Zingiber officinale Identifies GABAergic Signaling as a Potential Therapeutic Mechanism in Colorectal Cancer
Colorectal cancer cases are on the rise and have become a leading cause of cancer-related deaths. Ginger (Zingiber officinale) is widely used in traditional herbal medicine and has been proposed as a potential treatment for colorectal cancer. This study aimed to explore the network pharmacology and pharmacodynamics of ginger in colorectal cancer treatment. Colorectal cancer patient data from the GEO dataset were analyzed to identify differentially expressed genes (DEGs). Six key components of ginger were selected based on specific criteria, and their target proteins were predicted using the TCMSP database. By overlapping DEGs with predicted targets, 36 candidate drug targets were identified. These targets were analyzed for biological alterations, pathway enrichment, protein–protein interactions, and hub-gene selection, integrating network pharmacology. Molecular docking simulations were conducted to confirm the binding interactions between ginger components and target proteins. The findings showed that GABAergic signaling and apoptosis were the most enriched pathways, suggesting their potential role in colorectal cancer treatment. Docking simulations further revealed that ginger’s active compounds bind to COX2 and ESR1, indicating anti-inflammatory effects and modulation of estrogenic activity. This study provides insight into the systemic mechanisms of ginger in colorectal cancer treatment through an integrated “drug–gene–pathway–disease” network approach.
- 17 April 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (7) , 2975-2991
Perfluorooctane sulfonic acid: a possible risk factor of endothelial dysfunction based on in silico and in vitro studies
Perfluorooctane sulfonic acid (PFOS) is a fluorinated chemical utilized in a variety of industrial and household products. PFOS has been detected in human serum and is associated with multiple human adverse health effects. Epidemiological evidence has linked PFOS exposure to endothelial dysfunction, which is a key contributor to atherosclerosis. However, the underlying mechanisms of PFOS-induced endothelial dysfunction associated atherosclerosis has not been investigated. In the present study, human microvascular endothelial cells (HMEC-1) exposed to PFOS (15 μM) for 72 h, mimicking long-term exposure. We further employed integrated RNA-sequencing (RNA-seq) and transcriptomic analysis to identify differentially expressed genes (DEGs) for biological alterations: gene ontology (GO), pathway enrichment analysis (KEGG), protein–protein interaction network and modular clustering analysis. Furthermore, the Metascape database was used for disease association, tissue specificity, and transcription factor analysis. Hub genes were verified using atherosclerosis patient data sets from the GEO dataset. Alteration of hub genes in patients was then validated using immunoblotting and ELISA. Our results revealed that PFOS altered amino acid biosynthesis, lipid metabolism and induced the ER-stress response through the HRI/eIF2α/ATF4 pathway, leading to endothelial dysfunction. Interestingly, we found that PFOS induced inflammation by increasing COX-2, ICAM-1 and IL-6 expression through NF-κB and JAK2/STAT3 pathway in endothelial cells. Moreover, up-regulated C/EBPβ and ATF4 were observed in both patients and PFOS-exposed endothelium, which may use as an early biomarker and may have a potential role in PFOS-induced endothelial dysfunction. These findings provide novel insight into the underlying molecular mechanisms of PFOS-induced endothelial dysfunction associated with atherosclerosis.
- 17 April 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (7) , 2975-2991
Perfluorooctane sulfonic acid: a possible risk factor of endothelial dysfunction based on in silico and in vitro studies
Perfluorooctane sulfonic acid (PFOS) is a fluorinated chemical utilized in a variety of industrial and household products. PFOS has been detected in human serum and is associated with multiple human adverse health effects. Epidemiological evidence has linked PFOS exposure to endothelial dysfunction, which is a key contributor to atherosclerosis. However, the underlying mechanisms of PFOS-induced endothelial dysfunction associated atherosclerosis has not been investigated. In the present study, human microvascular endothelial cells (HMEC-1) exposed to PFOS (15 μM) for 72 h, mimicking long-term exposure. We further employed integrated RNA-sequencing (RNA-seq) and transcriptomic analysis to identify differentially expressed genes (DEGs) for biological alterations: gene ontology (GO), pathway enrichment analysis (KEGG), protein–protein interaction network and modular clustering analysis. Furthermore, the Metascape database was used for disease association, tissue specificity, and transcription factor analysis. Hub genes were verified using atherosclerosis patient data sets from the GEO dataset. Alteration of hub genes in patients was then validated using immunoblotting and ELISA. Our results revealed that PFOS altered amino acid biosynthesis, lipid metabolism and induced the ER-stress response through the HRI/eIF2α/ATF4 pathway, leading to endothelial dysfunction. Interestingly, we found that PFOS induced inflammation by increasing COX-2, ICAM-1 and IL-6 expression through NF-κB and JAK2/STAT3 pathway in endothelial cells. Moreover, up-regulated C/EBPβ and ATF4 were observed in both patients and PFOS-exposed endothelium, which may use as an early biomarker and may have a potential role in PFOS-induced endothelial dysfunction. These findings provide novel insight into the underlying molecular mechanisms of PFOS-induced endothelial dysfunction associated with atherosclerosis.
- 7 November 2023
- Published by Springer Nature in Biochemical Genetics
- Vol. 62 (4) , 2382-2398
Integrated Transcriptomics and Network Analysis Identified Altered Neural Mechanisms in Frontal Aging Brain-Associated Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common neurodegenerative disease. The late stage of AD typically develops after 60 years of age and AD pathogenesis can be detected predominately in the frontal lobe, which is responsible for memory. Multiple alterations in cellular mechanisms have been associated with AD, but there is no clear information on AD pathogenesis during brain aging. This study aimed to explore the differentially expressed genes (DEGs) in the frontal lobe of aging brains and to identify shared crucial mechanisms in the aging brain linked to AD pathogenesis. Three datasets were downloaded from the Gene Expression Omnibus (GEO). Biological function analysis was performed by DAVID and KEGG databases. An AD patient’s cohort (GSE150696) was collected for verification of the enriched pathway. The results demonstrated that multiple neurochemical synapsis and regulation of the cytoskeleton are linked to AD pathogenesis during aging. Taken together, this study contributes to our further understanding of neural alterations during aging in AD that could be used to develop therapeutics for early intervention to prevent or slow progression.
- 7 November 2023
- Published by Springer Nature in Biochemical Genetics
- Vol. 62 (4) , 2382-2398
Integrated Transcriptomics and Network Analysis Identified Altered Neural Mechanisms in Frontal Aging Brain-Associated Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common neurodegenerative disease. The late stage of AD typically develops after 60 years of age and AD pathogenesis can be detected predominately in the frontal lobe, which is responsible for memory. Multiple alterations in cellular mechanisms have been associated with AD, but there is no clear information on AD pathogenesis during brain aging. This study aimed to explore the differentially expressed genes (DEGs) in the frontal lobe of aging brains and to identify shared crucial mechanisms in the aging brain linked to AD pathogenesis. Three datasets were downloaded from the Gene Expression Omnibus (GEO). Biological function analysis was performed by DAVID and KEGG databases. An AD patient’s cohort (GSE150696) was collected for verification of the enriched pathway. The results demonstrated that multiple neurochemical synapsis and regulation of the cytoskeleton are linked to AD pathogenesis during aging. Taken together, this study contributes to our further understanding of neural alterations during aging in AD that could be used to develop therapeutics for early intervention to prevent or slow progression.
- Open Access
- 1 January 2023
- Published by SAGE Publications in Bioinformatics and Biology Insights
- Vol. 17
Integrated Transcriptomics and Network Analysis of Potential Mechanisms and Health Effects of Convalescent COVID-19 Patients
Coronaviral disease 2019 (COVID-19) is a recent pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, there are still cases of COVID-19 around the world that can develop into persistent symptoms after discharge. The constellation of symptoms, termed long COVID, persists for months and can lead to various diseases such as lung inflammation and cardiovascular disease, which may lead to considerable financial burden and possible risk to human health. Moreover, the molecular mechanisms underlying the post-pandemic syndrome of COVID-19 remain unclear. In this study, we aimed to explore the molecular mechanism, disease association, and possible health risks in convalescent COVID-19 patients. Gene expression data from a human convalescent COVID-19 data set was compared with a data set from healthy normal individuals in order to identify differentially expressed genes (DEGs). To determine biological function and potential pathway alterations, the GO and KEGG databases were used to analyze the DEGs. Disease association, tissue, and organ-specific analyses were used to identify possible health effects. A total of 250 DEGs were identified between healthy and convalescent COVID-19 subjects. The biological function alterations identified revealed cytokine interactions and increased inflammation through NF-κB1, RELA, JUN, STAT3, and SP1. Interestingly, the most significant pathways were cytokine-cytokine receptor interaction, altered lipid metabolism, and atherosclerosis that play a crucial role in convalescent COVID-19. In addition, we also found pneumonitis, dermatitis, and autoimmune diseases. Based on our study, convalescent COVID-19 is associated with inflammation in a variety of organs that could lead to autoimmune and inflammatory diseases, as well as atherosclerosis. These findings are a first step toward fully exploring the disease mechanisms in depth to understand the relationship between post-COVID-19 infection and potential health risks. This is necessary for the development of appropriate strategies for the prevention and treatment of long COVID.
- 1 January 2023
- Published by SAGE Publications in Bioinformatics and Biology Insights
- Vol. 17
Open AccessIntegrated Transcriptomics and Network Analysis of Potential Mechanisms and Health Effects of Convalescent COVID-19 Patients
Coronaviral disease 2019 (COVID-19) is a recent pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, there are still cases of COVID-19 around the world that can develop into persistent symptoms after discharge. The constellation of symptoms, termed long COVID, persists for months and can lead to various diseases such as lung inflammation and cardiovascular disease, which may lead to considerable financial burden and possible risk to human health. Moreover, the molecular mechanisms underlying the post-pandemic syndrome of COVID-19 remain unclear. In this study, we aimed to explore the molecular mechanism, disease association, and possible health risks in convalescent COVID-19 patients. Gene expression data from a human convalescent COVID-19 data set was compared with a data set from healthy normal individuals in order to identify differentially expressed genes (DEGs). To determine biological function and potential pathway alterations, the GO and KEGG databases were used to analyze the DEGs. Disease association, tissue, and organ-specific analyses were used to identify possible health effects. A total of 250 DEGs were identified between healthy and convalescent COVID-19 subjects. The biological function alterations identified revealed cytokine interactions and increased inflammation through NF-κB1, RELA, JUN, STAT3, and SP1. Interestingly, the most significant pathways were cytokine-cytokine receptor interaction, altered lipid metabolism, and atherosclerosis that play a crucial role in convalescent COVID-19. In addition, we also found pneumonitis, dermatitis, and autoimmune diseases. Based on our study, convalescent COVID-19 is associated with inflammation in a variety of organs that could lead to autoimmune and inflammatory diseases, as well as atherosclerosis. These findings are a first step toward fully exploring the disease mechanisms in depth to understand the relationship between post-COVID-19 infection and potential health risks. This is necessary for the development of appropriate strategies for the prevention and treatment of long COVID.